BACKGROUND: An inverted region on chromosome 17 has been previously linked to many Pick complex diseases. Due to the inversion, an exact causal locus has been difficult to identify, but the microtubule-associated protein tau gene is a likely candidate gene for its involvement in these diseases with tau inclusion. OBJECTIVE: To search for variants that confer susceptibility to 4 tauopathies and clinically related disorders. DESIGN: Genomewide association study. SETTING: University research laboratory. PARTICIPANTS: A total of 231 samples were genotyped from an unrelated white population of patients with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), frontotemporal dementia, and frontotemporal dementia with amyotrophy. Unaffected individuals from the same population were used as controls. MAIN OUTCOME MEASURES: The results from an inverted region of chromosome 17 that contains the MAPT gene. Genotypes of cases and controls were compared using a Fisher exact test on a marker-by-marker basis. Haplotypes were determined by visually inspecting genotypes. RESULTS: Comparing any particular disease and controls, the association was constant across the inverted chromosome segment. Significant associations were seen for PSP and PSP combined with CBD. Of the 2 haplotypes seen in the region, H1 was overrepresented in PSP and CBD cases compared with controls. CONCLUSIONS: As expected, the markers are highly correlated and the association is seen across the entire region, which makes it difficult to narrow down a disease-causing variant or even a possible candidate gene. However, considering the pathologic abnormalities of these diseases and the involvement of tau mutations seen in familial forms, the MAPT gene represents the most likely cause driving the association.
BACKGROUND: An inverted region on chromosome 17 has been previously linked to many Pick complex diseases. Due to the inversion, an exact causal locus has been difficult to identify, but the microtubule-associated protein tau gene is a likely candidate gene for its involvement in these diseases with tau inclusion. OBJECTIVE: To search for variants that confer susceptibility to 4 tauopathies and clinically related disorders. DESIGN: Genomewide association study. SETTING: University research laboratory. PARTICIPANTS: A total of 231 samples were genotyped from an unrelated white population of patients with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), frontotemporal dementia, and frontotemporal dementia with amyotrophy. Unaffected individuals from the same population were used as controls. MAIN OUTCOME MEASURES: The results from an inverted region of chromosome 17 that contains the MAPT gene. Genotypes of cases and controls were compared using a Fisher exact test on a marker-by-marker basis. Haplotypes were determined by visually inspecting genotypes. RESULTS: Comparing any particular disease and controls, the association was constant across the inverted chromosome segment. Significant associations were seen for PSP and PSP combined with CBD. Of the 2 haplotypes seen in the region, H1 was overrepresented in PSP and CBD cases compared with controls. CONCLUSIONS: As expected, the markers are highly correlated and the association is seen across the entire region, which makes it difficult to narrow down a disease-causing variant or even a possible candidate gene. However, considering the pathologic abnormalities of these diseases and the involvement of tau mutations seen in familial forms, the MAPT gene represents the most likely cause driving the association.
Authors: Hreinn Stefansson; Agnar Helgason; Gudmar Thorleifsson; Valgerdur Steinthorsdottir; Gisli Masson; John Barnard; Adam Baker; Aslaug Jonasdottir; Andres Ingason; Vala G Gudnadottir; Natasa Desnica; Andrew Hicks; Arnaldur Gylfason; Daniel F Gudbjartsson; Gudrun M Jonsdottir; Jesus Sainz; Kari Agnarsson; Birgitta Birgisdottir; Shyamali Ghosh; Adalheidur Olafsdottir; Jean-Baptiste Cazier; Kristleifur Kristjansson; Michael L Frigge; Thorgeir E Thorgeirsson; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson Journal: Nat Genet Date: 2005-01-16 Impact factor: 38.330
Authors: Marc Cruts; Rosa Rademakers; Ilse Gijselinck; Julie van der Zee; Bart Dermaut; Tim de Pooter; Peter de Rijk; Jurgen Del-Favero; Christine van Broeckhoven Journal: Hum Mol Genet Date: 2005-05-11 Impact factor: 6.150
Authors: M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton Journal: Hum Mol Genet Date: 1999-04 Impact factor: 6.150
Authors: K A Josephs; R C Petersen; D S Knopman; B F Boeve; J L Whitwell; J R Duffy; J E Parisi; D W Dickson Journal: Neurology Date: 2006-01-10 Impact factor: 9.910
Authors: C Conrad; A Andreadis; J Q Trojanowski; D W Dickson; D Kang; X Chen; W Wiederholt; L Hansen; E Masliah; L J Thal; R Katzman; Y Xia; T Saitoh Journal: Ann Neurol Date: 1997-02 Impact factor: 10.422
Authors: Elena Campoy; Marta Puig; Illya Yakymenko; Jon Lerga-Jaso; Mario Cáceres Journal: Philos Trans R Soc Lond B Biol Sci Date: 2022-06-13 Impact factor: 6.671
Authors: Elliot C Nelson; Arpana Agrawal; Michele L Pergadia; Jen C Wang; John B Whitfield; F Scott Saccone; Jason Kern; Julia D Grant; Andrew J Schrage; John P Rice; Grant W Montgomery; Andrew C Heath; Alison M Goate; Nicholas G Martin; Pamela A F Madden Journal: Addict Biol Date: 2010-01 Impact factor: 4.280
Authors: H Rob Taal; Beate St Pourcain; Elisabeth Thiering; Shikta Das; Dennis O Mook-Kanamori; Nicole M Warrington; Marika Kaakinen; Eskil Kreiner-Møller; Jonathan P Bradfield; Rachel M Freathy; Frank Geller; Mònica Guxens; Diana L Cousminer; Marjan Kerkhof; Nicholas J Timpson; M Arfan Ikram; Lawrence J Beilin; Klaus Bønnelykke; Jessica L Buxton; Pimphen Charoen; Bo Lund Krogsgaard Chawes; Johan Eriksson; David M Evans; Albert Hofman; John P Kemp; Cecilia E Kim; Norman Klopp; Jari Lahti; Stephen J Lye; George McMahon; Frank D Mentch; Martina Müller; Paul F O'Reilly; Inga Prokopenko; Fernando Rivadeneira; Eric A P Steegers; Jordi Sunyer; Carla Tiesler; Hanieh Yaghootkar; Monique M B Breteler; Stephanie Debette; Myriam Fornage; Vilmundur Gudnason; Lenore J Launer; Aad van der Lugt; Thomas H Mosley; Sudha Seshadri; Albert V Smith; Meike W Vernooij; Alexandra If Blakemore; Rosetta M Chiavacci; Bjarke Feenstra; Julio Fernandez-Benet; Struan F A Grant; Anna-Liisa Hartikainen; Albert J van der Heijden; Carmen Iñiguez; Mark Lathrop; Wendy L McArdle; Anne Mølgaard; John P Newnham; Lyle J Palmer; Aarno Palotie; Annneli Pouta; Susan M Ring; Ulla Sovio; Marie Standl; Andre G Uitterlinden; H-Erich Wichmann; Nadja Hawwa Vissing; Charles DeCarli; Cornelia M van Duijn; Mark I McCarthy; Gerard H Koppelman; Xavier Estivill; Andrew T Hattersley; Mads Melbye; Hans Bisgaard; Craig E Pennell; Elisabeth Widen; Hakon Hakonarson; George Davey Smith; Joachim Heinrich; Marjo-Riitta Jarvelin; Vincent W V Jaddoe Journal: Nat Genet Date: 2012-04-15 Impact factor: 38.330
Authors: Lianne M Reus; Bogdan Pasaniuc; Danielle Posthuma; Toni Boltz; Yolande A L Pijnenburg; Roel A Ophoff Journal: Biol Psychiatry Date: 2021-01-09 Impact factor: 12.810
Authors: Simone de Jong; Iouri Chepelev; Esther Janson; Eric Strengman; Leonard H van den Berg; Jan H Veldink; Roel A Ophoff Journal: BMC Genomics Date: 2012-09-06 Impact factor: 3.969